Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RSV
RSV
Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers
Fierce Pharma
Wed, 12/1/21 - 11:46 pm
Sanofi
vaccines
RSV
Flu
MRNA
pneumococcal disease
RSVVW 2021 – Pfizer gets maternal
EP Vantage
Mon, 11/1/21 - 11:01 pm
Pfizer
RSV
vaccines
RSVpreF
RSVVW
Johnson & Johnson May Not Have to Wait Long for Its Next Blockbuster Vaccine
Motley Fool
Tue, 10/19/21 - 10:45 am
JNJ
RSV
vaccines
clinical trials
J&J heats up RSV race with new vaccine data
BioPharma Dive
Mon, 10/4/21 - 10:58 pm
JNJ
RSV
vaccines
clinical trials
Could This Be Pfizer's Next Blockbuster Vaccine?
Motley Fool
Fri, 09/10/21 - 11:00 am
Pfizer
vaccines
RSV
RSVpreF
clinical trials
GSK, J&J and Pfizer vie for $10B RSV vaccine market, with Bavarian Nordic and Moderna hot on their trail
Endpoints
Tue, 09/7/21 - 12:03 pm
GSK
JNJ
Pfizer
Bavarian Nordic
Moderna Therapeutics
RSV
vaccines
Pfizer, marking fast research pace, starts key trial of RSV vaccine
BioPharma Dive
Thu, 09/2/21 - 09:59 pm
Pfizer
clinical trials
RSV
vaccines
Bavarian Nordic gets a vaccine booster
EP Vantage
Thu, 09/2/21 - 09:18 am
Bavarian Nordic
vaccines
RSV
MVA-BN RSV
Icosavax’s $182M IPO haul is key for RSV, but eyes are on its Covid vaccine too
MedCity News
Sun, 08/1/21 - 11:53 pm
IPOs
Icosavax
RSV
vaccines
Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbo charge work
Fierce Biotech
Fri, 07/30/21 - 11:08 am
Pfizer
RSV
vaccines
GSK
JNJ
clinical trials
Moderna plans triple vaccine targeting flu, COVID and RSV
Pharmaforum
Thu, 07/8/21 - 10:58 am
Moderna Therapeutics
vaccines
COVID-19
Flu
RSV
Sanofi, AstraZeneca mark big leap toward filing of RSV drug in 2022, with safety data in hand to challenge Synagis
Endpoints
Mon, 06/28/21 - 10:58 am
Sanofi
AstraZeneca
RSV
clinical trials
nirsevimab
Synagis
AstraZeneca and Sanofi Announce Big Breakthrough With RSV Vaccine
BioSpace
Mon, 04/26/21 - 10:41 am
AstraZeneca
Sanofi
vaccines
RSV
nirsevimab
clinical trials
Moderna advancing early stage mRNA prospects to show depth beyond COVID-19 shot
Fierce Biotech
Wed, 04/14/21 - 09:38 am
Moderna Therapeutics
vaccines
mRNA-1345
RSV
COVID-19
GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study
Biopharma Reporter
Tue, 11/24/20 - 10:49 am
GSK
vaccines
RSV
clinical trials
GSK sees 'robust immune response' from RSV vaccine hopefuls
Fierce Pharma
Wed, 10/21/20 - 10:38 am
GSK
RSV
vaccines
clinical trials
As Moderna doubles down on vaccines, Merck pulls out of a long-running collaboration
Endpoints
Thu, 10/8/20 - 11:03 am
Moderna Therapeutics
COVID-19
vaccines
Merck
RSV
Icosavax raises $51M to take VLP RSV vaccine into humans
Fierce Biotech
Thu, 10/3/19 - 10:40 am
Icosavax
vaccines
RSV
VLP
viruslike particle
IVX-121
Meissa raises $30M to take RSV vaccine into the clinic
Fierce Biotech
Thu, 09/26/19 - 10:48 am
Meissa Vaccines
vaccines
RSV
clinical trials
Enanta's lung infection therapy succeeds in mid-stage trial
Reuters
Fri, 06/14/19 - 06:28 pm
Enanta Pharmaceuticals
RSV
clinical trials
EDP-938
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »